These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 16459994

  • 1. Tuberous sclerosis complex: molecular pathogenesis and animal models.
    Piedimonte LR, Wailes IK, Weiner HL.
    Neurosurg Focus; 2006 Jan 15; 20(1):E4. PubMed ID: 16459994
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complex.
    Zeng LH, Rensing NR, Zhang B, Gutmann DH, Gambello MJ, Wong M.
    Hum Mol Genet; 2011 Feb 01; 20(3):445-54. PubMed ID: 21062901
    [Abstract] [Full Text] [Related]

  • 5. The tuberous sclerosis complex genes in tumor development.
    Mak BC, Yeung RS.
    Cancer Invest; 2004 Feb 01; 22(4):588-603. PubMed ID: 15565817
    [Abstract] [Full Text] [Related]

  • 6. Tuberous sclerosis: a syndrome of incomplete tumor suppression.
    McCall T, Chin SS, Salzman KL, Fults DW.
    Neurosurg Focus; 2006 Jan 15; 20(1):E3. PubMed ID: 16459993
    [Abstract] [Full Text] [Related]

  • 7. Simultaneous loss of hamartin and tuberin from the cerebrum, kidney and heart with tuberous sclerosis.
    Mizuguchi M, Ikeda K, Takashima S.
    Acta Neuropathol; 2000 May 15; 99(5):503-10. PubMed ID: 10805093
    [Abstract] [Full Text] [Related]

  • 8. Co-localization of TSC1 and TSC2 gene products in tubers of patients with tuberous sclerosis.
    Johnson MW, Emelin JK, Park SH, Vinters HV.
    Brain Pathol; 1999 Jan 15; 9(1):45-54. PubMed ID: 9989450
    [Abstract] [Full Text] [Related]

  • 9. TSC2 missense mutations inhibit tuberin phosphorylation and prevent formation of the tuberin-hamartin complex.
    Nellist M, Verhaaf B, Goedbloed MA, Reuser AJ, van den Ouweland AM, Halley DJ.
    Hum Mol Genet; 2001 Dec 01; 10(25):2889-98. PubMed ID: 11741832
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evidence for separable functions of tuberous sclerosis gene products in mammalian cell cycle regulation.
    Miloloza A, Kubista M, Rosner M, Hengstschläger M.
    J Neuropathol Exp Neurol; 2002 Feb 01; 61(2):154-63. PubMed ID: 11853018
    [Abstract] [Full Text] [Related]

  • 12. Pathological mutations in TSC1 and TSC2 disrupt the interaction between hamartin and tuberin.
    Hodges AK, Li S, Maynard J, Parry L, Braverman R, Cheadle JP, DeClue JE, Sampson JR.
    Hum Mol Genet; 2001 Dec 01; 10(25):2899-905. PubMed ID: 11741833
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Tuberous sclerosis complex: genetics to pathogenesis.
    Narayanan V.
    Pediatr Neurol; 2003 Nov 01; 29(5):404-9. PubMed ID: 14684235
    [Abstract] [Full Text] [Related]

  • 15. Loss of expression of tuberin and hamartin in tuberous sclerosis complex-associated but not in sporadic angiofibromas.
    Fackler I, DeClue JE, Rust H, Vu PA, Kutzner H, Rütten A, Kaddu S, Sander CA, Volkenandt M, Johnson MW, Vinters HV, Wienecke R.
    J Cutan Pathol; 2003 Mar 01; 30(3):174-7. PubMed ID: 12641776
    [Abstract] [Full Text] [Related]

  • 16. Tuberous sclerosis complex and DNA repair.
    Habib SL.
    Adv Exp Med Biol; 2010 Mar 01; 685():84-94. PubMed ID: 20687497
    [Abstract] [Full Text] [Related]

  • 17. Tuberin phosphorylation regulates its interaction with hamartin. Two proteins involved in tuberous sclerosis.
    Aicher LD, Campbell JS, Yeung RS.
    J Biol Chem; 2001 Jun 15; 276(24):21017-21. PubMed ID: 11290735
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Tuberous sclerosis: immunohistochemistry expression of tuberin and hamartin in a 31-week gestational fetus.
    Vinaitheerthan M, Wei J, Mizuguchi M, Greco A, Barness EG.
    Fetal Pediatr Pathol; 2004 Jun 15; 23(4):241-9. PubMed ID: 16095035
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.